LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE890.00-5.4 (-0.6 %)
PREV CLOSE ( ) 895.40
OPEN PRICE ( ) 893.00
BID PRICE (QTY) 890.05 (71)
OFFER PRICE (QTY) 890.95 (115)
VOLUME 44022
TODAY'S LOW / HIGH ( )885.00 905.25
52 WK LOW / HIGH ( )723.55 1090
NSE896.20-0.45 (-0.05 %)
PREV CLOSE( ) 896.65
OPEN PRICE ( ) 888.00
BID PRICE (QTY) 896.20 (399)
OFFER PRICE (QTY) 896.50 (15)
VOLUME 798056
TODAY'S LOW / HIGH( ) 884.25 905.80
52 WK LOW / HIGH ( )723.65 1090
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Deshbandhu Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupinworld.com

Website www.lupinworld.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
16Oct Lupin’s arm partners with ASHA, NPWH
Lupin’s wholly owned subsidiary in US -- Lupin Pharmaceuticals -- has pa..
16Oct Lupin rises with arm partnering with A
Lupin is currently trading at Rs. 897.00, up by 16.55 points or 1.88% fr..
16Oct Lupin informs about press release
Lupin has informed about press release titled ‘Survey Data Reveals the N..
15Oct Lupin receives tentative approval from
Lupin has received tentative approval for its Lurasidone Hydrochloride T..
15Oct Lupin strengthens on the BSE
Lupin is currently trading at Rs. 874.25, up by 28.90 points or 3.42% fr..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit4294.813446.6
Gross Profit 5621.5 17939.3
Operating Profit 6738.822169.8
Net Sales 25791.1100881.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Mercury Laboratories (BSE)
 419.90 (4.97%)
M.Cap (Rs. in Cr)50.39
Biocon (BSE)
 653.50 (2.70%)
M.Cap (Rs. in Cr)39429.00
Sanofi India (BSE)
 5929.95 (0.24%)
M.Cap (Rs. in Cr)13700.46
Neuland Laboratories (BSE)
 585.00 (2.27%)
M.Cap (Rs. in Cr)750.55
Astrazeneca Pharma I (BSE)
 1665.50 (0.77%)
M.Cap (Rs. in Cr)4156.88
Shareholding Pattern
PROMOTERS 47%
NON-INSTITUTION 15.3%
MUTUAL FUNDS/UTI 6.5%
FI/BANKS/INSURANCE 5.54%
GOVERNMENT 0.26%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.